Company intelligence / Profile preview

The DNA Repair Company

Princeton, New Jersey, USA

Ownership: Private
Development stage: Other

Overview

The DNA Repair Company (TDRC) was a molecular diagnostics firm specializing in personalized medicine for oncology. The company developed assays designed to predict a patient's likelihood of responding to specific chemotherapies by analyzing the activity and methylation status of DNA repair genes. Its primary focus was the MGMT gene, which serves as a critical predictor of response to alkylating agents in brain cancer patients. In 2008, the company was acquired by OncoMethylome Sciences (now MDxHealth) to expand its portfolio of pharmacogenomic tests. The acquisition allowed for the integration of TDRC's proprietary DNA repair capacity assays into a broader clinical diagnostic offering.

Therapeutic areas: Oncology
Modalities: Diagnostic testMolecular diagnostics
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on The DNA Repair Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The DNA Repair Company.

Explore the full profile